Results 191 to 200 of about 61,057 (265)
Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System. [PDF]
Yajima A, Uesawa Y.
europepmc +1 more source
Successful Treatment of Crohn Disease and Concomitant Alopecia Totalis with Upadacitinib: Case Report and Systematic Review of the Literature. [PDF]
Andersen YMF +3 more
europepmc +1 more source
Dermatophytes can be isolated from both symptomatic and asymptomatic cats, yet the role of skin commensals in modulating disease expression remains unclear. This study investigates whether microbial skin communities influence the clinical presentation (symptomatic or asymptomatic) of dermatophyte infection in Persian cats.
Aline E. Santana +2 more
wiley +1 more source
Genetic associations between polyunsaturated fatty acids and alopecia areata. [PDF]
Liu Q, Cai Y, Li W, Shi W, Yu L, Cai X.
europepmc +1 more source
Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs
Kosuke Horita +3 more
wiley +1 more source
Artificial Intelligence‐Based Identification of Common Canine Skin Lesions From Clinical Images
Background: Accurate evaluation of skin lesions is an essential component of dermatological examination, yet it can be time‐consuming and subject to interobserver variability. While artificial intelligence (AI) models have shown reliability in diagnosing specific skin diseases, lesion‐level identification remains underexplored in veterinary dermatology.
Soh‐Yoon Kang +8 more
wiley +1 more source
Real-World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi-Center Cohort Study. [PDF]
Jin Y +7 more
europepmc +1 more source
Background: Oclacitinib is a Janus kinase inhibitor approved for the treatment of pruritus associated with allergic dermatitis in dogs and may be effective in horses. Objectives: To evaluate the efficacy of oclacitinib in reducing pruritus and skin lesions in horses with allergic dermatitis.
Nuttawut Nuchprayoon +6 more
wiley +1 more source
Short-term omalizumab as a potential rescue therapy for alopecia areata flares during Janus kinase inhibitor maintenance. [PDF]
Wang Q +9 more
europepmc +1 more source
Abstract This case report describes pituitary abscess syndrome (PAS) in a 20‐month‐old Blonde d'Aquitaine heifer with cranial nerve deficits (V, VII, VIII, IX, X and XII) associated with facial hemiparesis, head tilt, ataxia and dysphagia, pneumonia and otitis interna.
Chloé Saada +4 more
wiley +1 more source

